MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Aspects of Quality of Life in MSA and PSP

    L. Wiblin, M. Lee, D. Burn (Newcastle-upon-Tyne, United Kingdom)

    Objective: The aim of this study was exploring  the correlation between disease severity and QoL in PSP and MSA. Background: MSA and PSP are atypical Parkinsonian disorders that…
  • 2017 International Congress

    Perceived facilitators and barriers in communicating with family member among people with Parkinson’s Disease: A focus group study

    J. Lee, Y. Kim (Seoul, Republic of Korea)

    Objective: The purpose of this study was to identify perceived facilitators and barriers for better communication with family member among people with Parkinson’s disease (PD).…
  • 2017 International Congress

    Assessing the extent of carer strain in Parkinson’s disease

    R. Varadarassou, V. Queen, E. Pearson, F. Murphy, M. Turner, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate the extent of carer strain in newly diagnosed Parkinson’s disease (PD) compared with that in long-standing PD, to inform development of carer-support…
  • 2017 International Congress

    Gait Analysis in Orthostatic Tremor treated with Thalamic Deep Brain Stimulation

    T.K. Tareen, A. Duker, G. Mandybur, J. Tuazon, M. Rosso, A. Espay, A. Fasano, A. Merola (Cincinnati, OH, USA)

    Objective: To evaluate the effects of Thalamic Deep Brain Stimulation (DBS) on Gait in Orthostatic tremor (OT) Background: OT is a rare hyperkinetic disorder of…
  • 2017 International Congress

    Quantitative measures of brain MRI as a predictive factor of cognitive outcomes after Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s disease

    L. Weinkle, J. Tanabe, B. Hoyt, J. Thompson, J. Honce, O. Klepitskaya (Aurora, CO, USA)

    Objective: To explore whether pre-surgical white matter lesion volume, measured quantitatively on brain MR images, is predictive of cognitive outcomes following subthalamic nucleus deep brain…
  • 2017 International Congress

    Degree, onset and longevity of benefit achieved with Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) as assessed by the UPDRS.

    D. Caputo, O. Mark, D. Schneider, R. DiPaola, S. Danish, E. Hargreaves (New Brunswick, NJ, USA)

    Objective:  To show the degree, onset and longevity of benefit achieved with STN DBS at our center. Background: At our center, we administer the UPDRS-III…
  • 2017 International Congress

    Comparison of subthalamic and pallidal deep brain stimulation in treatment of Parkinson’s disease: a 5-year follow-up study

    A. Gamaleya, A. Tomskiy, A. Dekopov, E. Bril, A. Poddubskaya, N. Fedorova, V. Shabalov (Moscow, Russian Federation)

    Objective: To assess and compare the long-term motor and functional outcome of subthalamic (STN) and pallidal (GPi) deep brain stimulation (DBS) in treatment of patients…
  • 2017 International Congress

    A Novel Deep Brain Stimulation Programming Paradigm for Parkinson’s disease

    J. Karl, L. Verhagen, D. Ocegueda (Chicago, IL, USA)

    Objective: To report the outcome of a novel interleaving stimulation (ILS) DBS programming paradigm (PP). Background: DBS of the STN using conventional high frequency (130-185Hz)…
  • 2017 International Congress

    Excellent Non-motor Responses after Bilateral Subthalamic Deep Brain Stimulation in Parkinson’s Disease Patient with SNCA Duplication

    J. Youn, J.W. Cho, J.-I. Lee (Seoul, Republic of Korea)

    Objective: We report a case of Parkinson's disease patient with SNCA duplication, who showed excellent response in both motor and non-motor symptoms after bilateral subthalamic stimulation. Background:…
  • 2017 International Congress

    Deutetrabenazine is Associated with an Improvement in Involuntary Movements in Patients With Tardive Dyskinesia as Seen by the High Proportion of Responders to Deutetrabenazine Treatment in the AIM-TD Study

    J. Jimenez-Shahed, H. Fernandez, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, W. Ondo, K. Anderson (Houston, TX, USA)

    Objective: To examine response rates between patients receiving deutetrabenazine and placebo. Response levels were pre-specified from 10–90% improvement from baseline in Abnormal Involuntary Movement Scale…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 155
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley